Related references
Note: Only part of the references are listed.Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
May H. Han et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis
Pablo Villoslada et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Profiling and Identification of Cerebrospinal Fluid Proteins in a Rat EAE Model of Multiple Sclerosis
Therese Rosenling et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions
Paola Picotti et al.
NATURE METHODS (2012)
Animal models of multiple sclerosis: the good, the bad and the bottom line
Richard M. Ransohoff
NATURE NEUROSCIENCE (2012)
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis
Marek J. Noga et al.
METABOLOMICS (2012)
Identification of Protein Networks Involved in the Disease Course of Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis
Annelies Vanheel et al.
PLOS ONE (2012)
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis
Alessandro S. Farias et al.
PROTEOMICS (2012)
Inflammation, demyelination, and degeneration - Recent insights from MS pathology
Christine Stadelmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis
Lionel Blanchet et al.
BMC BIOINFORMATICS (2011)
The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: From rat to human
Therese Rosenling et al.
CLINICA CHIMICA ACTA (2011)
Comprehensive Tissue Processing Strategy for Quantitative Proteomics of Formalin-fixed Multiple Sclerosis Lesions
Linda Ly et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
A. C. Kroksveen et al.
JOURNAL OF PROTEOMICS (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Rapid empirical discovery of optimal peptides for targeted proteomics
Andrew B. Stergachis et al.
NATURE METHODS (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
The formation of cerebrospinal fluid: Nearly a hundred years of interpretations and misinterpretations
D. Oreskovic et al.
BRAIN RESEARCH REVIEWS (2010)
The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification
Shalini Makawita et al.
CLINICAL CHEMISTRY (2010)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
Vitamin D and multiple sclerosis
Alberto Ascherio et al.
LANCET NEUROLOGY (2010)
High-throughput generation of selected reaction-monitoring assays for proteins and proteomes
Paola Picotti et al.
NATURE METHODS (2010)
Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis
Violaine K. Harris et al.
NEUROBIOLOGY OF DISEASE (2010)
Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
Marcel P. Stoop et al.
PLOS ONE (2010)
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis
Karen Wolburg-Buchholz et al.
ACTA NEUROPATHOLOGICA (2009)
Systems Biology and Its Application to the Understanding of Neurological Diseases
Pablo Villoslada et al.
ANNALS OF NEUROLOGY (2009)
Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics
Paola Picotti et al.
CELL (2009)
Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
Eric Kuhn et al.
CLINICAL CHEMISTRY (2009)
CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
F. G. Joseph et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Quantitative Matrix-Assisted Laser Desorption Ionization-Fourier Transform Ion Cyclotron Resonance (MALDI-FT-ICR) Peptide Profiling and Identification of Multiple-Sclerosis-Related Proteins
Marcel P. Stoop et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Heat Stabilization of the Tissue Proteome: A New Technology for Improved Proteomics
Marcus Svensson et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests
Tanguy Fortin et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma
Michael A. Kuzyk et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Disease Biomarkers in Multiple Sclerosis Potential for Use in Therapeutic Decision Making
Violaine K. Harris et al.
MOLECULAR DIAGNOSIS & THERAPY (2009)
Targeted proteomic strategy for clinical biomarker discovery
Ralph Schiess et al.
MOLECULAR ONCOLOGY (2009)
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis
E. Fainardi et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Protein expression profiles in pediatric multiple sclerosis: potential biomarkers
K. N. Rithidech et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Molecular network of the comprehensive multiple sclerosis brain-lesion proteome
J. I. Satoh et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma
Terri A. Addona et al.
NATURE BIOTECHNOLOGY (2009)
Cerebrospinal fluid biomarkers in multiple sclerosis
Hayrettin Tumani et al.
NEUROBIOLOGY OF DISEASE (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis
H. Tumani et al.
NEUROSCIENCE LETTERS (2009)
Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
Ralf A. Linker et al.
PLOS ONE (2009)
Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord
Mohit Raja Jain et al.
PROTEOME SCIENCE (2009)
Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis
Archana M. Jastorff et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Primary-progressive multiple sclerosis (vol 6, pg 903, 2007)
D. Miller et al.
LANCET NEUROLOGY (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis
D. Chiasserini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?
Haleem J. Issaq et al.
EXPERT REVIEW OF PROTEOMICS (2008)
A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis
M. Soilu-Haenninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring
Vinzenz Lange et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry
Marcel P. Stoop et al.
PROTEOMICS (2008)
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites
Jianru Stahl-Zeng et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Primary-progressive multiple sclerosis
David H. Miller et al.
LANCET NEUROLOGY (2007)
Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis
Frida Lundmark et al.
NATURE GENETICS (2007)
Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis
Simon G. Gregory et al.
NATURE GENETICS (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord
Tong Liu et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Widespread demyelination in the cerebellar cortex in multiple sclerosis
Alexandra Kutzelnigg et al.
BRAIN PATHOLOGY (2007)
Quantitative shotgun proteomics using a protease with broad specificity and normalized spectral abundance factors
Boris L. Zybailov et al.
MOLECULAR BIOSYSTEMS (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors
Laurence Florens et al.
METHODS (2006)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications
Wei-Jun Qian et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae
Boris Zybailov et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Ralf Gold et al.
BRAIN (2006)
Lumbar cerebrospinal fluid proteome in multiple sclerosis: Characterization by ultrafiltration, liquid chromatography, and mass spectrometry
Jean-Paul Noben et al.
JOURNAL OF PROTEOME RESEARCH (2006)
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis
Lawrence Steinman et al.
ANNALS OF NEUROLOGY (2006)
Charting protein complexes, signaling pathways, and networks in the immune system
A Bauch et al.
IMMUNOLOGICAL REVIEWS (2006)
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
L Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics
HJ Lee et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Grey matter pathology in multiple sclerosis
L Bo et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
S Sriram et al.
ANNALS OF NEUROLOGY (2005)
A data integration methodology for systems biology
D Hwang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Comparison of label-free methods for quantifying human proteins by shotgun proteomics
WM Old et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Genomics and proteomics: role in the management of multiple sclerosis
L Kappos et al.
JOURNAL OF NEUROLOGY (2005)
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein
Y Ishihama et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Modular transcriptional activity characterizes the initiation and progression of autoimmune encephalomyelitis
SE Baranzini et al.
JOURNAL OF IMMUNOLOGY (2005)
Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?
SM Ibrahim et al.
CURRENT OPINION IN NEUROLOGY (2005)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement
MS Freedman et al.
ARCHIVES OF NEUROLOGY (2005)
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis, and prognosis
D Miller et al.
LANCET NEUROLOGY (2005)
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis
S Cepok et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Proteomics analysis of human cerebrospinal fluid
XL Yuan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid
Z Jing et al.
NEUROBIOLOGY OF AGING (2005)
Differential proteomics via probabilistic peptide identification scores
J Colinge et al.
ANALYTICAL CHEMISTRY (2005)
Trends in survival and cause of death in Danish patients with multiple sclerosis
H Bronnum-Hansen et al.
BRAIN (2004)
Vitamin D intake and incidence of multiple sclerosis
KL Munger et al.
NEUROLOGY (2004)
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology
NJ Abbott
NEUROCHEMISTRY INTERNATIONAL (2004)
Biomarker discovery and validation:: technologies and integrative approaches
SE Ilyin et al.
TRENDS IN BIOTECHNOLOGY (2004)
A model for random sampling and estimation of relative protein abundance in shotgun proteomics
HB Liu et al.
ANALYTICAL CHEMISTRY (2004)
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents
PL Ross et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Development of biomarkers in multiple sclerosis
B Bielekova et al.
BRAIN (2004)
Multiple sclerosis as a generalized CNS disease - comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS
RLP Lindberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Current two-dimensional electrophoresis technology for proteomics
A Görg et al.
PROTEOMICS (2004)
Proteomic analysis of multiple sclerosis cerebrospinal fluid
BN Hammack et al.
MULTIPLE SCLEROSIS (2004)
Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process
E Mix et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Twin concordance and sibling recurrence rates in multiple sclerosis
CJ Willer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult
U Graumann et al.
BRAIN PATHOLOGY (2003)
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
IAF van der Mei et al.
BRITISH MEDICAL JOURNAL (2003)
Three or more routes for leukocyte migration into the central nervous system
RM Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2003)
A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard
A Alban et al.
PROTEOMICS (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement:: Evidence for different clinical cohorts -: Initial observations
O Gonen et al.
RADIOLOGY (2002)
Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry
PV Bondarenko et al.
ANALYTICAL CHEMISTRY (2002)
Large-scale proteomic analysis of the human splicesome
J Rappsilber et al.
GENOME RESEARCH (2002)
Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry
D Chelius et al.
JOURNAL OF PROTEOME RESEARCH (2002)
Tight junctions of the blood-brain barrier: Development, composition and regulation
H Wolburg et al.
VASCULAR PHARMACOLOGY (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
A Ascherio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Vitamin D: its role and uses in immunology
HF Deluca et al.
FASEB JOURNAL (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients
MP Molloy
ANALYTICAL BIOCHEMISTRY (2000)
Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage
HL Weiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Animal models for autoimmune demyelinating disorders of the nervous system
R Gold et al.
MOLECULAR MEDICINE TODAY (2000)
Peptide electroextraction for direct coupling of in-gel digests with capillary LC-MS/MS for protein identification and sequencing
AT Timperman et al.
ANALYTICAL CHEMISTRY (2000)
Share Paper
